U.S. Food and Drug Administration
FDA.gov Website Refresh
FDA is pleased to announce the launch of our newly redesigned public website. We are making website improvements to provide a more modern and customer-centric web experience.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Food & Beverages
Infusion Options Inc. Issues Voluntary Nationwide Recall of All Lots of All Sterile Products Due to Lack of Assurance of Sterility
Achievements in Tobacco Regulation Over the Past Decade and Beyond
CTP continues to regulate a complex and rapidly changing tobacco landscape by focusing on research, oversight, education, and compliance with federal laws.
FDA is Committed to Sound, Science-based Policy on CBD
FDA recognizes the significant public interest in products containing cannabis or cannabis-derived compounds, including CBD.
Supporting More Timely Development of Biologics for Patients
A robust market for safe, effective biosimilar products is crucial – more products on the market can lead to more access and reduced health care costs.
Guidance for Industry: Determining the Number of Employees for Purposes of the “Small Business” Definition in Parts 117 and 507
Animal & Veterinary, Food & Beverages
Guidance for Industry: Declaration of Added Sugars on Honey, Maple Syrup, Other Single-Ingredient Sugars and Syrups, and Certain Cranberry Products
Food & Beverages